Sign In

Jeroen Bakker

Partner at Novo Holdings

Jeroen Bakker is a Partner at Novo Holdings, specifically in the Seed Investments department. He joined Novo Holdings in September 2018, initially as a Principal, and has since been promoted to Partner.12

Jeroen has an extensive background in biotech and venture capital:

Education and Early Career

  • PhD in Immunology from the University of Amsterdam
  • MSc in Biomedical Sciences from Leiden University, with a specialization in entrepreneurship
  • BSc from the Technical University of Delft
  • Research Fellow at the La Jolla Institute for Allergy and Immunology in San Diego

Professional Experience

Before joining Novo Holdings, Jeroen worked at:

  • M Ventures (corporate venture capital arm of Merck) focusing on Seed and Series A investments
  • Various operational biotech roles in companies like Syntaxin (acquired by Ipsen), Inthera, and ISD Immunotech

Current Responsibilities

At Novo Holdings, Jeroen:

  • Holds several board positions
  • Led investments in companies such as Adcendo and Rappta Therapeutics
  • Focuses on identifying, building, and investing in innovative life science startups, particularly in the Nordic region

Board Positions

Jeroen currently serves on the boards of:

  • Adcendo
  • BiOrigin
  • Rappta Therapeutics
  • Antag Therapeutics

He previously held board positions at ISD-Immunotech and served as Interim Chief Business Officer there.2

Additional Information

Jeroen has also been involved in academic and professional organizations:

  • Chair of the Dutch Platform for Young Researchers in Nephrology
  • Member of REBBLS, a Danish networking organization for young biotech entrepreneurs

His LinkedIn username is indeed jeroenbakker, as mentioned in the query.2

Highlights

Jun 26 · linkedin

I recently spoke to Lucie Ellis-Taitt, following my recognition as one of In Vivo’s Rising Leaders.

It was great to discuss with Lucie Novo Holdings’ Seed Investments strategy and my passion for company creation in the biotech space, as well as the importance of creating talented leaders and cohesive teams. You can read the article using the link in the comments below.

I am honoured to have been recognised as one of In Vivo's Rising Leaders for 2024 alongside many talented CEOs, investors and entrepreneurs – thank you In Vivo (Citeline) for the recognition!   #InVivosRisingLeaders2024

May 10 · linkedin

The potential of the platform behind Commit Biologics is huge! Have look at the interview with CEO Krishna Polu at Endpoints News.

Related Questions

What are Jeroen Bakker's key achievements at Novo Holdings?
How did Jeroen Bakker's role at M Ventures influence his career?
What is the significance of Jeroen Bakker's investments in Adcendo and Rappta Therapeutics?
What are Jeroen Bakker's main responsibilities as a board member at various companies?
How did Jeroen Bakker's educational background prepare him for his career in biotech?
Jeroen Bakker
Jeroen Bakker, photo 1
Jeroen Bakker, photo 2
Add to my network

Location

Copenhagen, Capital Region of Denmark, Denmark